drugset / Trial / NCT03329560

Safety of FMT Using Oral Encapsulated PRIM-DJ2727 in HIV

NCT03329560 ↗

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether oral fecal microbiota transplantation (FMT) is safe for people with human immunodeficiency virus (HIV) infection.

Timeline

Start
2018-04-12
Primary completion
2019-10-08
Completion
2019-10-08

Drugs

EvaluationDrugModalityDoseRoute
Subject PRIM-DJ2727 Other / unclassified — Oral